International Conference on CRISPR Technologies

Enhancer Composition and Dosage Control Developmental Gene Expression

Authors

Anja Will - Presenter, 1. Max Planck Institute for Molecular Genetics
Giulia Cova, 1. Max Planck Institute for Molecular Genetics
Wing-Lee Chan, Charité–Universitätsmedizin Berlin
Martin Vingron, Max Planck Institute for Molecular Genetics
Axel Visel, Lawrence Berkeley National Laboratory
Darío Lupiáñez, Charité–Universitätsmedizin Berlin
Stefan Mundlos, Charité–Universitätsmedizin Berlin
Copy number variations (CNVs) often include noncoding sequences and putative enhancers, but how these rearrangements induce disease is poorly understood. We investigated CNVs involving the regulatory landscape of IHH (encoding Indian hedgehog), which cause multiple, highly localized phenotypes including craniosynostosis and synpolydactyly. We show through transgenic reporter and genome-editing studies in mice that Ihh is regulated by a constellation of at least nine enhancers with individual tissue specificities in the digit anlagen, growth plates, skull sutures and fingertips. Consecutive deletions, resulting in growth defects of the skull and long bones, showed that these enhancers function in an additive manner. Duplications, in contrast, caused not only dose-dependent upregulation but also misexpression of Ihh, leading to abnormal phalanges, fusion of sutures and syndactyly. Thus, precise spatiotemporal control of developmental gene expression is achieved by complex multipartite enhancer ensembles. Alterations in the composition of such clusters can result in gene misexpression and disease.